Takeda Pharmaceutical (TAK) Stock
Takeda Pharmaceutical (TAK) closed at $21.43 on Nov 13, 2026; its Tenet Score is 32 of 100 against 409 Healthcare peers.
3 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $21.43
- Nov 13, 2026
- Market cap
- $36.9Bunverified basis
- share basis not confirmed
- Dividend yield
- 2.94%
- past year's regular dividends ÷ price
- 52-week range
- 13.91 – 21.73
- low → high
- Tenet Score
- 32/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Takeda Pharmaceutical Co scores 32/100. Weak. Financial health is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 32 is built from 3 of 4 pillars, from 65% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Value omitted — no data yet.
Price
Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Income & Dividend Safety
Pays 2.94%. Yield is one component of total return.
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rar…
Common questions
What sector and industry is Takeda Pharmaceutical in?
Takeda Pharmaceutical is in the Healthcare sector and the Drugs industry.
What is Takeda Pharmaceutical's Tenet Score?
Takeda Pharmaceutical's Tenet Score is 32 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




